Androgen News and Research

RSS

New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis

Review examines the role of ferroptosis, an iron-dependent form of cell death, in prostate cancer, exploring its underlying molecular mechanisms and potential for targeted therapeutic strategies.

17 Apr 2024

Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels

For patients with locally advanced prostate cancer, combined treatment with chemotherapy and hormonal therapy offers extended control of prostate-specific antigen (PSA) levels, compared to hormonal therapy alone, reports a study in the April issue of The Journal of Urology, an Official Journal of the American Urological Association.

17 Apr 2024

Study sheds light on how androgens shape sex differences at the cellular and molecular levels

Sex differences are widespread across human development, physiological processes, and diseases, making it important to characterize the impact of sex differences in these areas.

12 Apr 2024

Study sheds light on the significance of glucocorticoid receptor in drug-resistant prostate cancer

New research from the University of Eastern Finland sheds light on the significance of the glucocorticoid receptor in drug-resistant prostate cancer, showing that the development of drug resistance could be prevented by limiting the activity of coregulator proteins.

10 Apr 2024

Newly discovered molecule may be a potential therapeutic target for triple-negative breast cancer

A team of researchers from Hiroshima University has discovered a molecule that promotes the production of cancer cells. This molecule may prove to be a potential therapeutic target in the treatment of triple-negative breast cancer, an aggressive form of breast cancer.

27 Mar 2024

Study demonstrates chemo-preventive properties of alpha-santalol against prostate cancer development

Extracted from the core of sandalwood trees (santalum album tree), sandalwood oil has been used for many centuries by several cultures throughout the world for perfume, soaps, incense and candles.

13 Feb 2024

Androgen receptor signaling found to upregulate gene driving melanoma severity in men

Method by which androgen-activated androgen receptors (ARs) increase fucosyltransferase 4 (FUT4) expression.

12 Feb 2024

Selective androgen receptor modulator has anti-tumor effects in ER-positive breast cancer patients

A research paper published today (8 February 2024) in The Lancet Oncology demonstrates that the drug enobosarm, a selective androgen receptor modulator which stimulates the male sex hormone receptor has anti-tumour effects in estrogen receptor positive breast cancer patients.

8 Feb 2024

Males born to obese women more likely to develop metabolic complications in later life

Males born to obese women are more likely to be overweight at birth and develop metabolic complications in later life, including liver disease and diabetes.

7 Feb 2024

Protein may hold key to restoring treatment response in drug-resistant neuroendocrine prostate cancer

It may be possible to restore drug-resistant neuroendocrine prostate cancer to a state that responds to treatment by depletion of a certain protein in cancer cells.

5 Feb 2024

Breakthrough gene-editing therapy transforms lives of patients with a hereditary disorder

A group of patients with a hereditary disorder have had their lives transformed by a single treatment of a breakthrough gene-editing therapy, according to the lead researcher.

2 Feb 2024

People with polycystic ovary syndrome may have memory and thinking problems in midlife

People with polycystic ovary syndrome may be more likely to have memory and thinking problems in middle age, according to new research published in the January 31, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

1 Feb 2024

Androgen News and Research

New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis

Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels

Study sheds light on how androgens shape sex differences at the cellular and molecular levels

Study sheds light on the significance of glucocorticoid receptor in drug-resistant prostate cancer

Newly discovered molecule may be a potential therapeutic target for triple-negative breast cancer

Study demonstrates chemo-preventive properties of alpha-santalol against prostate cancer development

Androgen receptor signaling found to upregulate gene driving melanoma severity in men

Selective androgen receptor modulator has anti-tumor effects in ER-positive breast cancer patients

Males born to obese women more likely to develop metabolic complications in later life

Protein may hold key to restoring treatment response in drug-resistant neuroendocrine prostate cancer

Breakthrough gene-editing therapy transforms lives of patients with a hereditary disorder

People with polycystic ovary syndrome may have memory and thinking problems in midlife

The effectiveness of statins in PCOS management

New review aims to help clinicians diagnose and manage PCOS

Research upends understanding of circadian clock in melanoma

Long-term prostate cancer treatment study informs decisions for diverse groups

Study uncovers 23 new genetic markers linked to kidney health on the X-chromosome

Rutgers researchers devise strategy to boost prostate cancer treatment efficacy

Spicing up the fight: Saffron's powerful impact on prostate cancer revealed

Atezolizumab plus carboplatin: A winning combination for metastatic triple-negative breast cancer

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News